NVCR Earnings

Quarterly EPS
$-0.28
Q3 2024
$-0.61
Q4 2024
$-0.31
Q1 2025
$-0.36
Q2 2025
$-0.33
Q3 2025
$-0.22
Q4 2025
$-0.62
Q1 2026
$-0.13
Q2 2026
Latest Revenue183.6M
Latest Net Income-15658000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.13183.6M-15658000+15.6%+63.9%
Q1 2026-$0.62174.1M-71138000+12.3%-100.0%
Q4 2025-$0.22174.3M-24499000+8.1%+63.9%
Q3 2025-$0.33167.2M-37270000+7.8%-17.9%
Q2 2025-$0.36158.8M-40139000+5.6%-16.1%
Q1 2025-$0.31155.0M-34319000+11.9%+13.9%
Q4 2024-$0.61161.3M-65922000+20.5%-38.6%
Q3 2024-$0.28155.1M-30570000+21.8%+39.1%
Q2 2024-$0.31150.4M-33375000
Q1 2024-$0.36138.5M-38760000
Q4 2023-$0.44133.8M-47079000
Q3 2023-$0.46127.3M-49485000
NovoCure (NVCR) — Earnings